342 related articles for article (PubMed ID: 9299819)
1. Prevalence of transmissible blood infections among blood donors at the University of Maiducuri Teaching Hospital, Maiduguri, Nigeria.
Chikwem JO; Mohammed I; Okara GC; Ukwandu NC; Ola TO
East Afr Med J; 1997 Apr; 74(4):213-6. PubMed ID: 9299819
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
El-Hazmi MM
Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
Aggarwal V; Prakash C; Yadav S; Chattopadhya D
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
[TBL] [Abstract][Full Text] [Related]
4. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
Fasola FA; Kotila TR; Akinyemi JO
Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
[TBL] [Abstract][Full Text] [Related]
5. Viral hepatitis in Nigeria--sickle-cell disease and commercial blood donors.
Mutimer DJ; Olomu A; Skidmore S; Olomu N; Ratcliffe D; Rodgers B; Mutimer HP; Gunson BK; Elias E
QJM; 1994 Jul; 87(7):407-11. PubMed ID: 7922292
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
[TBL] [Abstract][Full Text] [Related]
7. Increasing risk of transfusion-associated AIDS as the pandemic spreads: experience in Maiduguri, Nigeria.
Harry TO; Moses AE; Ola TO; Obi SO; Bajani MD
J Trop Med Hyg; 1993 Apr; 96(2):131-3. PubMed ID: 8459487
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation.
Okoroiwu HU; Okafor IM; Asemota EA; Okpokam DC
BMC Public Health; 2018 May; 18(1):645. PubMed ID: 29788937
[TBL] [Abstract][Full Text] [Related]
10. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
12. Blood transfusion related paediatric HIV/AIDS in Ile-Ife, Nigeria.
Adejuyigbe EA; Durosinmi MA; Onyia FN; Adeodu OO
AIDS Care; 2003 Jun; 15(3):329-35. PubMed ID: 12745396
[TBL] [Abstract][Full Text] [Related]
13. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
14. [Screening of infectious microorganisms in blood banks in Douala (1995-2004)].
Mogtomo ML; Fomekong SL; Kuate HF; Ngane AN
Sante; 2009; 19(1):3-8. PubMed ID: 19801344
[TBL] [Abstract][Full Text] [Related]
15. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
17. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors].
Mutlu B; Meriç M; Willke A
Mikrobiyol Bul; 2004 Oct; 38(4):445-8. PubMed ID: 15700672
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
[TBL] [Abstract][Full Text] [Related]
19. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria.
Buseri FI; Muhibi MA; Jeremiah ZA
Blood Transfus; 2009 Oct; 7(4):293-9. PubMed ID: 20011640
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus infection among blood donors and pregnant women in Maiduguri, Nigeria.
Harry TO; Bajani MD; Moses AE
East Afr Med J; 1994 Sep; 71(9):596-7. PubMed ID: 7875094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
